Posts Tagged 'SSRI'

New genetic test could help improve antidepressant use

In a column for Fox News, psychiatrist Dr. Keith Ablow writes of recently available laboratory testing that helps psychiatrists identify which antidepressants are the best match for a patient’s genetic makeup.

According to Ablow, medical professionals hope the testing may help counteract some of the documented drawbacks to antidepressants.

For example, Ablow notes that recent studies have suggested some antidepressants don’t work much better than placebos for many patients suffering from mild to ...

continue reading...

Creatine shows promise for treating depression

A recent study suggests that creatine, a supplement commonly used by athletes to help build muscle mass, is a promising treatment for depression.

According to an article in The Atlantic, researchers have previously found that creatine aids in treatment of depressed female rats. It was tested for the first time on depressed women as a booster to standard antidepressant treatment.

The Atlantic says the common antidepressants classified as selective serotonin reuptake inhibitors have ...

continue reading...

Antidepressant boom described as harmful

John Horgan, director of the Center for Science Writings at the Stevens Institute of Technology, wrote an article for the Chronicle of Higher Education in which he questions whether the surge in antidepressant prescriptions may be doing more harm than good.

In fact, he writes that clinical evidence suggests “American psychiatry, in collusion with the pharmaceutical industry, is perpetrating what may be the biggest case of iatrogenesis—harmful medical treatment—in history.”

When he first ...

continue reading...

GSK CEO addresses company’s fraud allegations

In an interview with reporters, GlaxoSmithKline chief executive officer Andrew Witty addressed the record $3 billion in penalties recently assessed against his company – including the question of whether jail time for company executives might be appropriate in such cases.

In a blog entry about the interview, the Philadelphia Inquirer’s David Sell mentions that Witty became CEO in May 2008, which is after the criminal conduct involved in the plea agreement. The GSK board of directors was aware of the investigation ...

continue reading...

Antidepressant makers commit ethical breaches

An entry on the blog The Poptort.com mentions a civil complaint by the U.S. attorney’s office in Boston against drug maker Forest Laboratories, alleging the company defrauded the government out of millions of dollars by illegally marketing Celexa and Lexapro, two versions of the anti-depressant, “citalopram,” for unapproved uses in children and adolescents.

Doctors are allowed to prescribe drugs for uses not approved by the FDA, but it’s illegal for companies to ...

continue reading...

GSK settlement has lessons for consumers

According to a Consumer Reports blog entry, the recent historic $3 billion settlement against pharmaceutical giant GlaxoSmithKline carries some important lessons for consumers.

Prescribing a drug “off-label,” or for a purpose different from the use specified in its U.S. Food and Drug Administration approval, is legal. But promoting a drug for off-label use is not.

And apparently GSK did exactly that, through tactics that included misrepresenting research data to show benefits and hide ...

continue reading...
Page 5 of 14 «...34567...»